Gratuit
En ligne
La Roche-Posay Laboratoire Dermatologique
4.5
· 1033 Avis
2000 places par session
Anglais
Pigmentary Disorders :
Unveiling insights on epidemiology, stigmatization, clinical perspectives, and a breakthrough innovation for hyperpigmentation
Join our broadcasted symposium during the IMCAS World Congress 2024 the 1st of February, chaired by Dr Hema SUNDARAM
14:30-14:40
PIGMENTARY DISORDERS WORLDWIDE SURVEY: EPIDEMIOLOGY, IMPACT ON QUALITY OF LIFE AND STIGMATIZATION
Dr. Delphine KEROB
Dermatologist, France
Scientific Director - La Roche-Posay
14:40-14:50
PRACTICE MANAGEMENT OF PIH
Dr. Hema SUNDARAM
Dermatologist, US
14:50-15:00
PRACTICE MANAGEMENT OF MELASMA
Dr. Hassan GALADARI
Dermatologist, UAE
15:00-15:10
NEW INGREDIENT TO DECREASE MELANIN PRECURSOR
Peggy SEXTIUS
Head of Laboratory, L’Oréal R&I
15:10-15:20
HYPERPIGMENTATION: CLINICAL RESULTS WITH THE LATEST LA ROCHE-POSAY INNOVATION
Dr. Delphine KEROB
Dermatologist, France
Scientific Director - La Roche-Posay
La Roche-Posay Laboratoire Dermatologique
4.5
· 1033 Avis